Latest news with #ParagDave
Time of India
27-04-2025
- Business
- Time of India
Guj leads pharma sector with record 183 new plants
1 2 3 Ahmedabad: Gujarat has further cemented its position as India's pharmaceutical powerhouse with the state's Food and Drug Control Administration (FDCA) approving 183 new allopathic drug manufacturing facilities in FY 2024-25, marking the highest number of approvals since the Covid-19 pandemic, reports Parag Dave. "We approved 183 new allopathic medicine plants last financial year, the highest for Gujarat and across India after 2020-21," said H G Koshia, commissioner, Gujarat FDCA. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad "Gujarat is a pharma hub, and these plants will soon be operational, further boosting our dominance. Since March 2019, we have cleared at least 800 new allopathic drug plants , firmly setting Gujarat on the path to becoming the world's pharmacy. The average investment per plant in FY 2024-25 is an estimated Rs 50 crore, but some companies are investing more. So we estimate total new investments to touch about Rs 12,000 crore, " he added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Don't Miss The Top Packaging Trends Of 2025 Enhance Your Brand With The Latest Insights Packaging Machines | Search Ads Search Now Undo Industry experts say that Gujarat's mature and well-established pharma ecosystem is driving this record-setting growth. Also, many units from northern India are shifting to Gujarat. Shrenik Shah, national joint secretary of the Indian Drug Manufacturers' Association (IDMA), said, "Many companies from Gujarat had set up manufacturing plants in tax havens around two decades ago, but after GST implementation, they have been moving back to Gujarat. Also, in the last two years, risk-based inspections have increased, resulting in many companies deciding to set up new plants in Gujarat, ensuring compliance with international regulatory standards." A director of a pharma company in Ahmedabad, requesting anonymity, said, "Gujarat commands at least 28% of India's pharma manufacturing and nearly 31% share in the country's pharma exports. Most of the new plants are aimed at the export market, especially Europe's highly regulated environment." "After the implementation of GST, Gujarat has seen steady new investments in the pharma sector. Tax havens lost their appeal after GST implementation and Gujarat's pharma ecosystem has become the preferred choice for companies," he further added. Ahmedabad: Gujarat has further cemented its position as India's pharmaceutical powerhouse with the state's Food and Drug Control Administration (FDCA) approving 183 new allopathic drug manufacturing facilities in FY 2024-25, marking the highest number of approvals since the Covid-19 pandemic, reports Parag Dave. "We approved 183 new allopathic medicine plants last financial year, the highest for Gujarat and across India after 2020-21," said H G Koshia, commissioner, Gujarat FDCA. "Gujarat is a pharma hub, and these plants will soon be operational, further boosting our dominance. Since March 2019, we have cleared at least 800 new allopathic drug plants, firmly setting Gujarat on the path to becoming the world's pharmacy. The average investment per plant in FY 2024-25 is an estimated Rs 50 crore, but some companies are investing more. So we estimate total new investments to touch about Rs 12,000 crore, " he added. Industry experts say that Gujarat's mature and well-established pharma ecosystem is driving this record-setting growth. Also, many units from northern India are shifting to Gujarat. Shrenik Shah, national joint secretary of the Indian Drug Manufacturers' Association (IDMA), said, "Many companies from Gujarat had set up manufacturing plants in tax havens around two decades ago, but after GST implementation, they have been moving back to Gujarat. Also, in the last two years, risk-based inspections have increased, resulting in many companies deciding to set up new plants in Gujarat, ensuring compliance with international regulatory standards." A director of a pharma company in Ahmedabad, requesting anonymity, said, "Gujarat commands at least 28% of India's pharma manufacturing and nearly 31% share in the country's pharma exports. Most of the new plants are aimed at the export market, especially Europe's highly regulated environment." "After the implementation of GST, Gujarat has seen steady new investments in the pharma sector. Tax havens lost their appeal after GST implementation and Gujarat's pharma ecosystem has become the preferred choice for companies," he further added.
Time of India
26-04-2025
- Business
- Time of India
Luxe homes maintenance rivals flat prices
Ahmedabad: If you believe that the price tag on an ultra-luxury apartment covers it all, you're in for a surprise. At the city's top-end addresses, buyers are handing over an additional Rs 40 lakh to Rs 2 crore — the cost of another upscale home —as one-time maintenance deposit, that too upfront, reports Parag Dave. Developers say it's the price of uninterrupted luxury living. For buyers, this is the new normal of hassle-free luxury living. Along the Iskcon-Ambli stretch, where duplex penthouses sprawl over a palatial 20,000 square feet, builders have pegged maintenance deposits at Rs 1,000 per square foot. That's Rs 2 crore upfront — locked in to create a Rs 60-crore corpus to maintain the glitzy premises that promises a luxury lifestyle with amenities, without flat owners having to shell out monthly maintenance fees for decades. "This is a 62-unit scheme in a 38-storey tower, standing 156m tall, one of the city's tallest residential buildings. We have added every luxury: a private theatre, grand banquet halls, gyms, pools, wellness centres and more. With Rs 5 per square foot monthly upkeep, cost to maintain the 6 lakh square feet space comes to Rs 30 lakh a month. Other apartments in the complex sprawl across 7,500-9,000 square feet, with maintenance costs coming to Rs 75-90 lakh. The corpus ensures smooth operations without residents having to argue about expenses later," said Rajan Shah, director of a leading realty group developing the project. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like CFD's: Investing $200 in Emaar Malls can give you a second income TradeLG Undo These mega-projects offer not just homes, but five-star lifestyles. Some luxury apartments include two kitchens, multiple family rooms, sprawling balconies, and separate spaces for formal and informal living. "One of our uber-luxurious residential projects has three swimming pools, a theatre for first-day releases with Dolby surround, banquet halls with attached kitchens, a fully air-conditioned building, residential guest suites, and even full-body massage rooms. Members pay Rs 700 per square foot as maintenance deposit — about Rs 75 lakh for a 10,700-square-foot home — because it guarantees a certain lifestyle without worrying about monthly upkeep," said Sunit Choksi, director of a real estate firm. "And here's the clincher — when owners sell these apartments, the maintenance deposit is refundable, making luxury accessible at zero monthly costs," he adds. The bar is set just as high elsewhere on Iskcon-Ambli Road. N K Patel, director of another real estate firm, said, "Our upcoming 8,000-square-foot apartments will require buyers to pay Rs 600 per square foot — around Rs 48 lakh per apartment — as maintenance deposit. With this corpus, the residents' welfare association will find managing the scale of amenities we are offering a breeze for years to come." Post-Covid, the appetite for such luxurious living has only grown. "Today's buyers want the club experience at home — minus the traffic jams. A well-maintained project doesn't just offer comfort; it also fetches a fat premium when owners eventually sell," said Dipak Patel, president of Credai Gujarat.
